Sfoglia per Autore
Log P in the bRo5 chemical space
2019-01-01 Maura Vallaro, Giuseppe Ermondi, Gilles Goetz, Marina Shalaeva, Sonja Visentin, Giulia Caron
Experimental lipophilicity for beyond Rule of 5 compounds
2019-01-01 Ermondi, Giuseppe; Vallaro, Maura; Goetz, Gilles; Shalaeva, Marina; Caron, Giulia
A mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies
2019-01-01 Pacheco DP, Butnarasu C, Bertoglio F, Suarez Vargas N, Briatico-Vangosa F, van Uden S, Visai L, Petrini P, Vallaro M, Caron G, Visentin S
The NFKBIA’s amplification in cancer, emerging molecular targets for lung cancer therapy
2019-01-01 Giovanna Carrà, Rocco Piazza, Giuseppe Ermondi, Giulia Caron, Chiara Riganti, Beatrice Maffeo, Antonio Cartellà, Marcello Francesco Lingua, Mara Brancaccio, Riccardo Taulli, Silvia Novello; Alessandro Morotti
Translating unusual computational methods to drug discovery: Taking advantage of work in other fields
2019-01-01 Caron G.; Ermondi G.
MLR, PLSR-BR Analysis and MBPLSR to Interpret Multivariate QSPR Models. The Case of a Micellar Liquid Chromatography Descriptor (log K WSDS )
2019-01-01 Ermondi G.; Caron G.
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w)
2019-01-01 Costamagna A.; Rossi Sebastiano M.; Natalini D.; Simoni M.; Valabrega G.; Defilippi P.; Visentin S.; Ermondi G.; Turco E.; Caron G.; Cabodi S.
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
2019-01-01 Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, Matilde Simoni, Giorgio Valabrega, Paola Defilippi, Sonja Visentin, Giuseppe Ermondi, Emilia Turco, Giulia Caron, Sara Cabodi
Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry
2019-01-01 Caron G.; Kihlberg J.; Ermondi G.
Learning how to use IAM chromatography for predicting permeability
2018-01-01 Ermondi, Giuseppe; Vallaro, Maura; Caron, Giulia
Block relevance (BR) analysis and polarity descriptors in property-based drug design
2018-01-01 Ermondi, Giuseppe; Caron, Giulia*
Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposes
2018-01-01 Ermondi, G.; Vallaro, M.; Camacho-Leal, M.P.; Potter, T.; Visentin, S.; Caron, G.*
Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?
2018-01-01 Poongavanam, Vasanthanathan; Danelius, Emma; Peintner, Stefan; Alcaraz, Lilian; Caron, Giulia; Cummings, Maxwell D.; Wlodek, Stanislaw; Erdelyi, Mate; Hawkins, Paul C. D.; Ermondi, Giuseppe*; Kihlberg, Jan
Log P as a tool in intramolecular hydrogen bond considerations
2018-01-01 Caron, Giulia*; Vallaro, Maura; Ermondi, Giuseppe
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs beyond the Rule of 5
2018-01-01 Rossi Sebastiano, Matteo; Doak, Bradley C.; Backlund, Maria; Poongavanam, Vasanthanathan; Over, Björn; Ermondi, Giuseppe; Caron, Giulia; Matsson, Pär*; Kihlberg, Jan
HTS Assay Development: an airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery
2017-01-01 Petrini, P.; Pacheco, D.; Visai, L.; Coletti, M.; Bertoglio, F.; Caron, G.; Visentin, S.
Airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery
2017-01-01 Petrini, P; Pacheco, Dp; Pontremoli, C.; Caron, G.; Visentin, S
Why we need to implement intramolecular hydrogen-bonding considerations in drug discovery
2017-01-01 Caron, Giulia; Ermondi, Giuseppe
Relationship between passive permeability and molecular polarity using block relevance analysis
2017-01-01 Goetz, Gilles H; Shalaeva, Marina; Caron, Giulia; Ermondi, Giuseppe; Philippe, Laurence
Updating molecular properties during early drug discovery
2017-01-01 Caron, Giulia; Ermondi, Giuseppe
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Log P in the bRo5 chemical space | 2019 | Maura Vallaro, Giuseppe Ermondi, Gilles Goetz, Marina Shalaeva, Sonja Visentin, Giulia Caron | |
Experimental lipophilicity for beyond Rule of 5 compounds | 2019 | Ermondi, Giuseppe; Vallaro, Maura; Goetz, Gilles; Shalaeva, Marina; Caron, Giulia | |
A mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies | 2019 | Pacheco DP, Butnarasu C, Bertoglio F, Suarez Vargas N, Briatico-Vangosa F, van Uden S, Visai L, Petrini P, Vallaro M, Caron G, Visentin S | |
The NFKBIA’s amplification in cancer, emerging molecular targets for lung cancer therapy | 2019 | Giovanna Carrà, Rocco Piazza, Giuseppe Ermondi, Giulia Caron, Chiara Riganti, Beatrice Maffeo, Antonio Cartellà, Marcello Francesco Lingua, Mara Brancaccio, Riccardo Taulli, Silvia Novello; Alessandro Morotti | |
Translating unusual computational methods to drug discovery: Taking advantage of work in other fields | 2019 | Caron G.; Ermondi G. | |
MLR, PLSR-BR Analysis and MBPLSR to Interpret Multivariate QSPR Models. The Case of a Micellar Liquid Chromatography Descriptor (log K WSDS ) | 2019 | Ermondi G.; Caron G. | |
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w) | 2019 | Costamagna A.; Rossi Sebastiano M.; Natalini D.; Simoni M.; Valabrega G.; Defilippi P.; Visentin S.; Ermondi G.; Turco E.; Caron G.; Cabodi S. | |
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. | 2019 | Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, Matilde Simoni, Giorgio Valabrega, Paola Defilippi, Sonja Visentin, Giuseppe Ermondi, Emilia Turco, Giulia Caron, Sara Cabodi | |
Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry | 2019 | Caron G.; Kihlberg J.; Ermondi G. | |
Learning how to use IAM chromatography for predicting permeability | 2018 | Ermondi, Giuseppe; Vallaro, Maura; Caron, Giulia | |
Block relevance (BR) analysis and polarity descriptors in property-based drug design | 2018 | Ermondi, Giuseppe; Caron, Giulia* | |
Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposes | 2018 | Ermondi, G.; Vallaro, M.; Camacho-Leal, M.P.; Potter, T.; Visentin, S.; Caron, G.* | |
Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations? | 2018 | Poongavanam, Vasanthanathan; Danelius, Emma; Peintner, Stefan; Alcaraz, Lilian; Caron, Giulia; Cummings, Maxwell D.; Wlodek, Stanislaw; Erdelyi, Mate; Hawkins, Paul C. D.; Ermondi, Giuseppe*; Kihlberg, Jan | |
Log P as a tool in intramolecular hydrogen bond considerations | 2018 | Caron, Giulia*; Vallaro, Maura; Ermondi, Giuseppe | |
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs beyond the Rule of 5 | 2018 | Rossi Sebastiano, Matteo; Doak, Bradley C.; Backlund, Maria; Poongavanam, Vasanthanathan; Over, Björn; Ermondi, Giuseppe; Caron, Giulia; Matsson, Pär*; Kihlberg, Jan | |
HTS Assay Development: an airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery | 2017 | Petrini, P.; Pacheco, D.; Visai, L.; Coletti, M.; Bertoglio, F.; Caron, G.; Visentin, S. | |
Airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery | 2017 | Petrini, P; Pacheco, Dp; Pontremoli, C.; Caron, G.; Visentin, S | |
Why we need to implement intramolecular hydrogen-bonding considerations in drug discovery | 2017 | Caron, Giulia; Ermondi, Giuseppe | |
Relationship between passive permeability and molecular polarity using block relevance analysis | 2017 | Goetz, Gilles H; Shalaeva, Marina; Caron, Giulia; Ermondi, Giuseppe; Philippe, Laurence | |
Updating molecular properties during early drug discovery | 2017 | Caron, Giulia; Ermondi, Giuseppe |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile